Comment
doi: 10.1176/appi.ajp.2016.16030320.
In Support of Neuroimaging Biomarkers of Treatment Response in First-Episode Schizophrenia
Affiliations
- PMID: 27363555
- PMCID: PMC6071671
- DOI: 10.1176/appi.ajp.2016.16030320
Item in Clipboard
Comment
In Support of Neuroimaging Biomarkers of Treatment Response in First-Episode Schizophrenia
Am J Psychiatry.
.
No abstract available
Conflict of interest statement
Dr. Malhotra is a consultant to Genomind, Inc, FORUM Pharmaceuticals, and Takeda Pharmaceuticals. Dr. Lencz has been a consultant to Eli Lilly. Dr. Sarpal reports no financial relationships with commercial interests.
Comment in
-
Response to Sarpal et al.: Importance of Neuroimaging Biomarkers for Treatment Development and Clinical Practice.Am J Psychiatry. 2016 Jul 1;173(7):733-4. doi: 10.1176/appi.ajp.2016.16030320r. Am J Psychiatry. 2016. PMID: 27363556 No abstract available.
Comment on
-
A Selective Review of Cerebral Abnormalities in Patients With First-Episode Schizophrenia Before and After Treatment.Am J Psychiatry. 2016 Mar 1;173(3):232-43. doi: 10.1176/appi.ajp.2015.15050641. Epub 2015 Dec 1. Am J Psychiatry. 2016. PMID: 26621570 Review.
Similar articles
-
A neuroimaging biomarker for striatal dysfunction in schizophrenia.Nat Med. 2020 Apr;26(4):558-565. doi: 10.1038/s41591-020-0793-8. Epub 2020 Mar 23. Nat Med. 2020. PMID: 32251404
-
Dissecting the Heterogeneity of Treatment Response in First-Episode Schizophrenia.Schizophr Bull. 2015 Nov;41(6):1224-6. doi: 10.1093/schbul/sbv117. Epub 2015 Sep 2. Schizophr Bull. 2015. PMID: 26333841 Free PMC article.
-
The effect of antipsychotic drugs on nonspecific inflammation markers in the first episode of schizophrenia.Vojnosanit Pregl. 2015 Dec;72(12):1085-92. doi: 10.2298/vsp140526016s. Vojnosanit Pregl. 2015. PMID: 26898032
-
Pharmacotherapy of first-episode schizophrenia.Br J Psychiatry Suppl. 1998;172(33):66-70. Br J Psychiatry Suppl. 1998. PMID: 9764129 Review.
-
Functional neuroimaging in treatment resistant schizophrenia: A systematic review.Neurosci Biobehav Rev. 2019 Sep;104:178-190. doi: 10.1016/j.neubiorev.2019.07.001. Epub 2019 Jul 2. Neurosci Biobehav Rev. 2019. PMID: 31276716
Cited by
-
Imaging-Based Subtyping for Psychiatric Syndromes.Neuroimaging Clin N Am. 2020 Feb;30(1):35-44. doi: 10.1016/j.nic.2019.09.005. Epub 2019 Nov 11. Neuroimaging Clin N Am. 2020. PMID: 31759570 Free PMC article. Review.
-
Emerging therapeutic targets for schizophrenia: a framework for novel treatment strategies for psychosis.Expert Opin Ther Targets. 2021 Jan;25(1):15-26. doi: 10.1080/14728222.2021.1849144. Epub 2020 Nov 26. Expert Opin Ther Targets. 2021. PMID: 33170748 Free PMC article. Review.
-
Psychoradiological patterns of small-world properties and a systematic review of connectome studies of patients with 6 major psychiatric disorders.J Psychiatry Neurosci. 2018 Nov 1;43(6):427. doi: 10.1503/jpn.170214. J Psychiatry Neurosci. 2018. PMID: 30375837 Free PMC article.
-
fMRI connectivity as a biomarker of antipsychotic treatment response: A systematic review.Neuroimage Clin. 2023;40:103515. doi: 10.1016/j.nicl.2023.103515. Epub 2023 Sep 23. Neuroimage Clin. 2023. PMID: 37797435 Free PMC article.
-
Psychoradiology: The Frontier of Neuroimaging in Psychiatry.Radiology. 2016 Nov;281(2):357-372. doi: 10.1148/radiol.2016152149. Radiology. 2016. PMID: 27755933 Free PMC article. Review.
References
-
- Gong Q, Lui S, Sweeney JA. Selective Review of Cerebral Abnormalities in Patients With First-Episode Schizophrenia Before and After Treatment. Am J Psychiatry. 2016;173:232–243. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
